Anti-GGT5 antibody produced in rabbit

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

GGT5 (γ-glutamyltransferase 5) gene encodes a protein belonging to the γ-glutamyl transpeptidase gene family. It cleaves the γ-glutamyl moiety of glutathione conjugates, such as antioxidants, inflammatory molecules, drug metabolites, and neuroactive compounds. It catalyzes the conversion of leukotriene C4 (LTC4) to leukotriene D4 (LTD4). It may be useful in the development of treatments for inflammatory diseases such as asthma and cardiovascular disease in humans. Increased levels of GGT have been observed in certain young Roma population in eastern Slovakia, and has been associated with metabolic syndrome. It functions as a pro-oxidant by generating reactive metabolite (CysGly) in the presence of iron and may be a part of a potential physiopathological oxidation system.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

γ-Glutamyltransferase 5 precursor recombinant protein epitope signature tag (PrEST)

Corresponding Antigen APREST73547

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany